AuNRs@MIL-101-based stimuli-responsive nanoplatform with supramolecular gates for image-guided chemo-photothermal therapy
J. Gao,H.-M. Yu,M. Wu,Q. Chen,Y. Yang,Y. Qu,M. Sun,J.-C. Qin,L. Ma,Y.-W. Yang
DOI: https://doi.org/10.1016/j.mtchem.2021.100716
IF: 7.613
2022-03-01
Materials Today Chemistry
Abstract:Multimodal theranostic nanoplatform with multi-functions in diagnosis and treatment could be achieved by combining inorganic nanoparticles and intelligent composite materials such as metal-organic frameworks. In this study, a stimuli-responsive theranostic nanoplatform with well-defined architectures and the capability of computed tomography imaging guidance, tumorous microenvironment-triggered drug release, and effective chemo-photothermal synergistic therapy has been designed by encapsulating gold nanorods (AuNRs) with MIL-101 metal-organic framework, followed by the installation of carboxylatopillar[5]arene (CP[5]A)-based supramolecular gates. The pillararene gates on the surface of the MIL-101 shell enhance the drug loading capacity of the carrier and endow the resulting hybrid AuNRs@MIL-101(Fe)–NH2@CP[5]A nanoparticles with controlled release function in response to multi-stimuli, including pH, temperature, and Ca2+ ion. The obtained AuNRs@MIL-101(Fe)–NH2@CP[5]A nanoparticles system allows the sustained release of anticancer drug 5-fluorouracil over five days for an effectively prolonged treatment, demonstrating the promising potential of a comprehensive multimodal theranostic nanoplatform in clinical investigations.
chemistry, multidisciplinary,materials science